NURS 1566 Clinical Form 3: Clinical Medications Worksheets Generic Name albuterol sulfate Peak 1.

5–2 hr Onset 5 min Classification
Sympathomimetic drug Beta2-selective adrenergic agonist Bronchodilator Antiasthmatic

Dose 2.5 mg

Route Inhalation

Time/frequency Q6h PRN

Duration 3–8 hr

Normal dosage range
Each actuation of aerosol dispenser delivers 90 mcg albuterol; 2 inhalations q 4–6 hr; some patients may require only 1 inhalation q 4 hr; more frequent administration or larger number of inhalations not recommended.

• Prevention of exercise-induced bronchospasm: 2 inhalations 15 min prior to exercise. Solution for inhalation 2.5 mg tid to qid by nebulization. Inhalation capsules One 200 mcg capsule q 4–6 hr up to two 200 mcg capsules q 4–6 hr. •
Prevention of exercise-induced asthma: One 200 mcg capsule inhaled 15 min before exercise.

Why is your patient getting this medication Relief and prevention of bronchospasm in patients with reversible obstructive airway disease Mechanism of action and indications (Why med ordered) In low doses, acts relatively selectively at beta2-adrenergic receptors to cause bronchodilation and vasodilation; at higher doses, beta2 selectivity is lost, and the drug acts at beta2 receptors to cause typical sympathomimetic cardiac effects.

For IV meds, compatibility with IV drips and/or solutions None Nursing Implications (what to focus on) Use minimal doses for minimal periods; drug tolerance can occur with prolonged use. Maintain a beta-adrenergic blocker (cardioselective beta-blocker, such as atenolol, should be used with respiratory distress) on standby in case cardiac arrhythmias occur. Prepare solution for inhalation by diluting 0.5 mL 0.5% solution with 2.5 mL normal saline; deliver over 5–15 min by nebulization. Do not exceed recommended dosage; administer pressurized inhalation drug forms during second half of inspiration, because the airways are open wider and the aerosol distribution is more extensive. Common side effects CNS: Restlessness, apprehension, anxiety, fear, CNS stimulation, hyperkinesia, insomnia, tremor, drowsiness, irritability, weakness, vertigo, headache CV: Cardiac arrhythmias, tachycardia, palpitations, PVCs (rare), anginal pain Dermatologic: Sweating, pallor, flushing GI: Nausea, vomiting, heartburn, unusual or bad taste GU: Increased incidence of leiomyomas of uterus when given in higher than human doses in preclinical studies Respiratory: Respiratory difficulties, pulmonary edema, coughing, bronchospasm, paradoxical airway resistance with repeated, excessive use of inhalation preparations
Lab value alterations caused by medicine

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this patient

Be sure to teach the patient the following about this medication Do not exceed recommended dosage; adverse effects or loss of effectiveness may result. Read the instructions that come with respiratory inhalant. These side effects may occur: Dizziness, drowsiness, fatigue, headache (use caution if driving or performing tasks that require alertness); nausea, vomiting, change in taste (eat small, frequent meals); rapid heart rate, anxiety, sweating, flushing, insomnia. Report chest pain, dizziness, insomnia, weakness, tremors or irregular heartbeat, difficulty breathing, productive cough, failure to respond to usual dosage.

psychoneurotic individuals. temperature. unstable vasomotor system disorders. R. history of stroke. tachyarrhythmias. hypertension. ECG Assessment Why would you hold or not give this med? If patient is experiencing any tachyarrhythmia. turgor.Nursing Process. or any coronary insufficiency the medication should not be given. Physical: Weight. BP. thyroid function tests. history of seizure disorders. serum electrolytes. reflexes.Assessment (Pre-administration assessment) History: Hypersensitivity to albuterol. CAD. Evaluation Check to make sure no allergic reactions or hypersensitivity occurs. diabetes mellitus. skin color. orientation. as well as any arrhythmias . affect. adventitious sounds. blood and urine glucose. coronary insufficiency. P. tachycardia caused by digitalis intoxication. general anesthesia with halogenated hydrocarbons or cyclopropane. hyperthyroidism. COPD patients who have developed degenerative heart disease.

Sign up to vote on this title
UsefulNot useful